期刊文献+

慢性肾功能不全患者心脏超声分析

Hemodialysis patients with cardiac ultrasound analysis
原文传递
导出
摘要 目的:观察血透患者心脏超声,了解发生心血管疾病(CVD)的结构基础.方法:采用彩色多普勒超声测定105例血透患者和101例非尿毒症人的左心房内径(LAD)、右心房内径(RAD)、左心室内径(LVD)、右心室内径(RVD)、室间隔厚度(IVS)、左心室后壁(LVPW)、左室心肌重量指数(LVMI)、舒张期快速充盈峰值(E)/舒张末期充盈峰值(A),并作比较.血透患者中有CVD表现组54例和无CVD表现组51例比较上述指标.结果:血透患者的LAD、RVD、LVD IVS、LVPW、LVMI显著高于对照组.CVD组年龄、IVS、LVPW、LVMI显著高于无CVD组.部分血透患者无CVD临床症状.结论:血透患者心脏结构的异常变化较为普遍且部分为亚临床损伤.血透患者CVD的发生与年龄、左心室肥厚相关. Objective: Observation of hemodialysis patients cardiac ultrasound, understanding the development of cardiovascular disease (CVD) the structural foundation. Methods: Using color Doppler ultrasound in 105 hemodialysis patients and 101 patients with non--uremic the left atrial diameter (LAD),and the right atrial diameter (RAD),left ventricular diameter (LVD),right ven- tricular diameter (RVD). septal thickness (IVS) ,left ventricular wall (IVS),left ventricular mass index (LVMI), diastolic peak fill- ing fast (E) / end--diastolic peak filling (A),and for comparison. Hemodialysis patients with CVD performance group and 54 pa- tients without CVD performance comparison group of 51 cases these indicators. Results: Hemodialysis patients with LAD, RVD, LVD,IVS,Indexes, LVMI significantly higher. CVD is an age group, IVS, Indexes, LVMI significantly higher than those without CVD group. Conclusion: Hemodialysis patients with abnormal heart structure significantly, some of which no clinical symptoms of CVD. hemodialysis patients suggest the abnormal heart structure changes more widespread part of subclinical injury, the incidence of CVD with ave. Left ventricular hvoertroohv related.
出处 《按摩与康复医学》 2011年第23期37-38,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 血透 心脏彩超 心房内径 心室内径 左心室后壁 室间隔厚度 左室心肌重量指数 心脏瓣膜 Hemodialysisechocardiography Atrial diameter Ventricular diameter Left ventricular wallseptal thickness Leftventricular mass index Heart Valve
  • 相关文献

参考文献8

  • 1Locatelli F, Marceili D, Conte F, et ai. Cardiovascular disease in chronic renal failure: the ehallenge cmunues[J]. Nephrol Dial Transplant, 2000,15 (Suppl 5), 69 - 70.
  • 2Cheung AK, Sarnak MJ, Yan S, et al. Cardiac disease in maintenance hemodialysis patients:Results of the HEMO study [J]. Kidney Int,2004,65(6) :2380-2389.
  • 3Herzog CA, Ma JZ,Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, eornary artery stenting, and coronary artery bypass surgery and impact of diabetes[J]. Circulation, 2002,106 : 2207-2211.
  • 4Foley RN, Parfrey PS. Cardiac disease in chronic uremia: clinical outcome and risk faetor[J]. Adv Ren Replace Ther, 1997,4 (3), 23.1-248.
  • 5侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 6Carmine Z. Cardiovascular risk in uraemic patients is it fully explained by classical risk factors[J]. Nephrol Dial Transplant,2000, 15:454-457.
  • 7Madhumathi Rao, Brian J. G. Pereira: Prospective Trials on anemia of chronic disease: The trial to reduce cardiovascular events with Aranesp therapy[J]. Kidney Int, 2003,64(Suppl 87) : S12-S19.
  • 8Sarnak MJ, Levey AS, Sehoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, ttigh Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention[J]. Hypertention, 200a, 42: 1050-1065.

二级参考文献16

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部